About

About Hyfe Hyfe is the global leader in providing continuous, passive cough monitoring as an endpoint for clinical trials and research. Hyfe’s CoughMonitor Suite is a smartwatch-based solution used in numerous regulatory-focused drug development trials, from proof of concept to Phase 3 studies, as an exploratory or primary endpoint across therapeutic areas including refractory chronic cough, bronchiectasis, COPD, and more. Hyfe’s CoughMonitor Suite is a validated, accurate, and fully privacy-preserving solution for continuous cough monitoring. Hyfe’s cough monitoring has been used in over 50 research trials and has resulted in over 20 peer-reviewed publications spanning more than 18 therapeutic indications. Hyfe is also developing an evidence-based digital therapeutic (DTx) solution for cough hypersensitivity, which recently reported over a 40% reduction in cough frequency over 4 weeks. Hyfe’s DTx is already licensed for development as a prescription DTx in Japan, and Hyfe is actively seeking partners to address cough hypersensitivity as a treatable trait of respiratory conditions (e.g., asthma, among others) in other global markets.